HomeCPRX • NASDAQ
Catalyst Pharmaceuticals Inc
add
$20.40
1.90%
After Hours:(1.21%)-0.25
$20.15
Closed: Sep 18, 5:36:22 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 146.56M | 19.44% |
Operating expense | 55.29M | 10.42% |
Net income | 52.11M | 27.73% |
Net profit margin | 35.55 | 6.95% |
Earnings per share | 0.68 | 21.43% |
EBITDA | 75.76M | 18.96% |
Effective tax rate | 24.80% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 652.80M | 73.76% |
Total assets | 971.92M | 37.59% |
Total liabilities | 115.89M | 18.61% |
Total equity | 856.03M | — |
Shares outstanding | 122.39M | — |
Price to book | 2.86 | — |
Return on assets | 17.62% | — |
Return on capital | 20.01% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 52.11M | 27.73% |
Cash from operations | 71.30M | 11.17% |
Cash from investing | -26.00K | -160.00% |
Cash from financing | 872.00K | -24.63% |
Net change in cash | 72.14M | 10.51% |
Free cash flow | 58.94M | 5.37% |
Previous close
$20.02
Day range
$20.01 - $20.41
Year range
$19.15 - $26.58
Market cap
2.50B USD
Avg Volume
1.63M
P/E ratio
12.37
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2002
Headquarters
Website
Employees
181
